Startup Funding Tracker
Home›Companies›Biotech & Pharma›Elucida Oncology

Elucida Oncology, Inc.

Biotech & Pharma
Updated Oct 27, 2026·Latest SEC filing Aug 3, 2023·Suggest an edit

About Elucida Oncology

Elucida Oncology is a private company based in Monmouth Junction, New Jersey. It has reported $117,111,488 raised in five offerings on Form D since August 2017. Its chief executive is Geno Germano.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 24, 2023Jun 15, 2023amended Aug 3, 2023$22,284,600fully sold107$208KDebt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Mar 11, 2022Mar 28, 2022$22,284,600fully sold107$208KDebt, Securities on exerciseRule 506(b)Form D ↗
Oct 28, 2020Nov 10, 2020amended Jan 12, 2021$35,000,000fully sold328$106KEquity, Securities on exerciseRule 506(b)Form D/A ↗3 earlier filings
May 13, 2020May 26, 2020amended Jun 4, 2020$8,782,683of $30.0M target126$69,704Equity, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Aug 15, 2017Aug 22, 2017amended Feb 7, 2019$28,759,605of $30.0M target175$164KEquity, OptionsRule 506(b)Form D/A ↗2 earlier filings
Total, five offerings$117,111,488

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Elucida Oncology's Form D filed Aug 3, 2023.

TB
Tim Boris
Director
Also a director at Vogenx.
RR
DZ
UW
GS
Gary Sender
Director
RE
Robert Essner
Executive officer and director
NM
GG
Geno Germano
CEO and director

Earlier filings also listed Somaiya Ian (executive officer, last listed Mar 2022), Kai Ma (executive officer, last listed Mar 2022), Gregory Adams (executive officer, last listed Mar 2022), Eliel Bayever (executive officer, last listed Mar 2022), Teresa Ressel (director, last listed Jan 2021), Michael Smith (director, last listed Jan 2021) and Isaac Blech (director, last listed Feb 2019).

Sources

  1. SECElucida Oncology, Inc. Form D, filed Jun 15, 2023
  2. SECElucida Oncology, Inc. Form D/A, filed Dec 29, 2020
  3. SECElucida Oncology, Inc. Form D/A, filed Dec 10, 2020
  4. SECElucida Oncology, Inc. Form D, filed Nov 10, 2020
  5. SECElucida Oncology, Inc. Form D, filed May 26, 2020
  6. SECElucida Oncology, Inc. Form D/A, filed Jan 3, 2019
  7. SECElucida Oncology, Inc. Form D, filed Aug 22, 2017
  8. SECElucida Oncology, Inc. filing history